Coelocanth, this is an interesting discovery, I was a little taken aback by the four to six study inflation between announcements. In fact I'm only aware of the two studies being conducted, Panoc and the small US study in locally advanced pancreatic cancer ,so what are the other 4 studies? Can somebody help? I could find nothing on the company website apart from the two I mention before, even in their "research" section, or anywhere else about another 4 oncosil device studies. It would seem an extraordinary omission for any biotech company to ignore two thirds of its development programme in its materials. Was there a problem with these 4 studies? Any assistance with this would be appreciated.
OSL Price at posting:
10.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)